Accreditation Review & Approval Committee Disclosures

*This individual disclosed a financial relationship(s) as listed below.  Otherwise, the individual has no financial relationships to disclose. 

All relevant financial relationships have been mitigated.

 *This individual disclosed a financial relationship(s) as listed below. 

Financial Relationships with Ineligible Companies
Saebom An (AZ) - Employment:  Becton and Dickinson
Thomas Bergquist, PhD, LP (MN) - Consultant: General Dynamics Information Technology
Sheena Crosby, PharmD (FL) - Advisory Board: Pharmacosmos Therapeutics Inc.
Angela Donaldson, MD (FL) - Honoraria: Sanofi Genzyme 
Chris Fox, MD (FL) - Honoraria: MainStay Medical, Inc.l Stock Equity: Hyperion Surgical; Von Vascular
Andy Herber, PA-C (MN) - Consultant: Medical Logix LLC
Mitchell Humphreys, MD (AZ) - Intellectual Property:  Endoluxe, Inc. | Honoraria:  BD Biosciences; Ethicon Endo-Surgery, Inc.; UroViu; Applaud Medical; Boston Scientific Corporation | Grant:  Boston Scientific; Cook Medical; Adva-Tech; Boston Scientific
Atul Jain, MD (AZ) - Stock Shareholder: Apple, Astra Zeneca, Doximity, Merck, Pfizer, Viatris, Inc.
Sanjeev Kakar, MD (MN) - Intellectual Property:  Arthrex, Inc.; OsteoApp.ai; restor3d, inc.; Innomed, Inc. | Honoraria:  Arthrex, Inc.; Medwest Associates, Inc.; Pinnacle Inc; Arthrex Global University; Steelhead Surgical; Summit Surgical; Endo Pharmaceuticals, Inc. | Consulting:  Arthrex; Restor3d | Stock Equity:  Orthobullets
Amanda Kellogg (MN) - Stock Shareholder: Aethlon Medical, Inc., Amazon, Intuitive Surgical, Inc., Medicenna Therapeutics
Christophe Lamb, MD (FL) - Grant: Immunovant, Inc.
Rami Manochakian, MD (FL) - Honoraria: AbbVie, Inc.; Alpha2 Pharmaceuticals;  AstraZeneca Pharmaceuticals LP; BMS Global, Inc.; Bristol-Myers Squibb Company; Cardinal Health, Inc.; Daiichi Sankyo, Inc.; Janssen Scientific Affairs, LLC; MJH Life Sciences; Novocure Inc.; OncoHost
Shyamal Mehta, MD (AZ) - Honoraria: AbbVie, Inc.; Adamas Pharmaceuticals, Inc.; Health & Wellness Partners Group LLC; Neurocrine Biosciences, Inc.; Scion NeuroStim LLC; Supernus Pharmaceuticals, Inc. 
Girish Mour, MBBS (AZ) - Speakers Activities: EVIMED
Shelley Noland, MD (AZ) - Honoraria: MicroAire; Intellectual Property: Skysong Innovations, LLC (fka Arizona Technology Enterprises LLC (AzTE)) 
William Palmer, MD (FL) - Honoraria: Insights Driven Research
Samir Patel, MD (AZ) - Honoraria: Galra Therapeutics, Inc.
Sandya Pruthi, MD (MN) - Stock Equity: Abbott, Abbvie, Becton Dickinson, Biontech, Cirsper, Embecta, Ilumina, Moderna
Devon Rubin, MD (FL) - Honoraria: Cadwell | Presentation Non-CME (external audience): Cadwell Laboratories
Niloy Jewel Samadder, MD (AZ) - Honoraria: Cancer Prevention Pharmaceuticals, Inc.; CARIS; Guardant Health, Inc.’ Janssen Research & Development, LLC; Nouscom AG; One Two Therapeutics; Recursion Pharmaceuticals, Inc.; Tempest Therapeutics; Tornado Therapeutics, Inc.
Jason Starr, DO (FL) - Consultant: Advanced Accelerator Applications; Helsinn; Horizon CME; Ipsen Biopharmaceuticals, Inc.; Natera; Pfizer, Inc.; Taiho Oncology, Inc.; Tempus; TerSera Therapeutics, LLC
Winston Tan, MD (FL) - Intellectual Property (IP): Champions Oncology
Rabih Tawk, MD (FL) - Stock Equity: Medtronic

All relevant financial relationships have been mitigated.

Inactive Committee and Staff
Laura Wilson (July 2025)
Shannon Halvorson (June 2025)
Melissa Tadeo (May 2025)
Wendy Heim (May 2025)
Adam Beamer, MBA (May 2025)
Kelly Hauger (May 2025)
Kathy Wallen (May 2025)
Jenny Ollila (April 2025)
Kelly Tanner (March 2025)
Ashley Cotto (March 2025)
Karla Flemke (March 2025)
Nicole Miller (February 2025)
Amanda Williams (January 2025)
Kalen Schou (January 2025)
Melynda Wirt (January 2025)
Peggy Paulson, MA (January 2025)
Chris Fox, MD* (January 2025)
Saebom An* (January 2025)
Mitchell Humphreys, MD* (January 2025)
Alison Bentley (December 2024)
Angie Yaghoubi (December 2024)
Shawn Teal (November 2024)
Debra Schapekahm-Timm (October 2024)
Klodia Kirro (August 2024)